Search Results - "Parker, Victoria L."

Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation by Rachaneni, Suneetha, McCooty, Shanteela, Middleton, Lee J, Parker, Victoria L, Daniels, Jane P, Coomarasamy, Arri, Verghese, Tina S, Balogun, Moji, Goranitis, Ilias, Barton, Pelham, Roberts, Tracy E, Deeks, Jonathan J, Latthe, Pallavi

“…Urodynamics (UDS) has been considered the gold standard test for detrusor overactivity (DO) in women with an overactive bladder (OAB). Bladder ultrasonography…”
Get full text

Factors associated with failed 'test of cure' in the NHS Cervical Screening Programme: A retrospective cohort study by Long, Emma, Macdonald, Madeleine C, Parker, Victoria L, Lyon, Rachel, Ellis, Kay, Palmer, Julia E

“…To determine predictive factors associated with failed 'test of cure' (TOC) in the NHS Cervical Screening Programme (NHSCSP). Retrospective cohort study of all…”
Get full text

High HIV prevalence in gestational trophoblastic neoplasia patients by Parker, Victoria L, Baker, Zoe L I, Stone, Benjamin J, Singh, Kamaljit, Winter, Matthew C, Palmer, Julia E

“…To assess the HIV prevalence in patients diagnosed with gestational trophoblastic neoplasia (GTN). A retrospective single centre cohort study. A database from…”
Get full text

PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia? by Parker, Victoria L., Winter, Matthew C., Tidy, John A., Hancock, Barry W., Palmer, Julia E., Sarwar, Naveed, Kaur, Baljeet, McDonald, Katie, Aguiar, Xianne, Singh, Kamaljit, Unsworth, Nick, Jabbar, Imran, Pacey, Allan A., Harrison, Robert F., Seckl, Michael J.

“…Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight‐variable International Federation of Gynaecology and Obstetrics (FIGO)…”
Get full text

PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia by Parker, Victoria L., Winter, Matthew C., Tidy, John A., Palmer, Julia E., Sarwar, Naveed, Singh, Kamaljit, Aguiar, Xianne, Hancock, Barry W., Pacey, Allan A., Seckl, Michael J., Harrison, Robert F.

“…The International Federation of Gynecology and Obstetrics (FIGO) scoring system uses the sum of eight risk-factors to predict single-agent chemotherapy…”
Get full text

Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia by Parker, Victoria L., Cushen, Bryony F., Hills, Annie, Kandiah, Kaveetha, Palmer, Julia E., Singh, Kamaljit, Hancock, Barry W., Tidy, John A., Winter, Matthew C.

“…Single-agent methotrexate (MTX) is commonly used as first-line treatment for low-risk gestational trophoblastic neoplasia (LR-GTN), although no international…”
Get full text

Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia by Parker, Victoria L., Winter, Matthew C., Whitby, Elspeth, Parker, William A. E., Palmer, Julia E., Tidy, John A., Pacey, Allan A., Hancock, Barry W., Harrison, Robert F.

“…Background The International Federation of Gynaecology and Obstetrics (FIGO) score identifies gestational trophoblastic neoplasia (GTN) patients as low- or…”
Get full text

Comparison and optimisation of microRNA extraction from the plasma of healthy pregnant women by Parker, Victoria L, Cushen, Bryony F, Gavriil, Eleftherios, Marshall, Benjamin, Waite, Sarah, Pacey, Allan, Heath, Paul R

“…Circulating microRNA (miRNA) biomarkers are implicated in the diagnosis, monitoring and prediction of various disease processes. Before embarking upon…”
Get full text

Profiling microRNAs in uncomplicated pregnancies: Serum vs. plasma by Parker, Victoria L, Gavriil, Eleftherios, Marshall, Benjamin, Pacey, Allan, Heath, Paul R

“…Blood-derived microRNAs (miRNAs/miRs) are ideal clinical biomarkers, as they can be relatively non-invasively extracted and are stable across a range of…”
Get full text

Benefits and Challenges of Robotic Pelvic Surgery in a Cardiac Transplant Recipient by Parker, Victoria L., Parker, William A. E., Davies, Holly M., Ramshaw, Helen J., D’Arcy, Emma K., Al-Mohammad, Abdallah, Mateszko, Olena, Kew, Fiona M., Braidley, Peter C.

Get full text

Current management of gestational trophoblastic disease by Parker, Victoria L., Tidy, John A.

“…Gestational trophoblastic disease incorporates a spectrum of disorders ranging from benign to malignant subtypes. At one end, hCG level monitoring is all that…”
Get full text

Current management of gestational trophoblastic disease by Parker, Victoria L., Tidy, John A.

“…Gestational trophoblastic disease incorporates a spectrum of disorders ranging from benign to malignant subtypes. At one end of the condition, hCG level…”
Get full text